Response From Biogen to SMA UK & MDUKs' Letter

03 May 2019

Following SMA UK and MDUK sending a flyer and letters urging Biogen, NHS England and NICE to work strenuously this week so that on May 8th, the NICE committee can endorse an agreement for access to nusinersen for all with SMA Types 1, 2 and 3, we have received a response from Biogen which can you read by clicking through the link below:

Response from Biogen